LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Home・Listă Acțiuni・Prothena Corp PLC

Prothena Corp PLC

Deschisă

Sector Sănătate

21.95 -0.86

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

21.63

Maxim

22.42

Indicatori cheie
By Trading Economics
Venit	-72M
Vânzări	-266K 50K
EPS	-1.34
Marjă de profit	-144,478
EBITDA	-81M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+214.34 upside

Dividende
By Dow Jones
Următoarele câștiguri	31 oct. 2024

Statistici piață
By TradingEconomics
Capitalizare de piață	38M 1.2B
Deschiderea anterioară	22.81
Închiderea anterioară	21.95

Sentimentul știrilor

By Acuity

41%

59%

85 / 365 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bullish Evidence

20.74 / 22.83 Suport & Rezistență

Prothena Corp PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

28 mai 2024, 22:51 UTC

Market Talk

Achiziții, Fuziuni, Preluări

Bristol Myers Squibb Adds to Neurodegenerative Treatment Investments -- Market Talk

Comparație

Modificare preț

Prothena Corp PLC Așteptări

Obiectiv de preț

By TipRanks

214.34% sus

Prognoză pe 12 luni

Medie 69.5 USD 214.34%

Maxim 94 USD

Minim 24 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruProthena Corp PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

6 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 6 analiști care au acordat evaluări ale acțiunilor Prothena Corp PLC - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

20.74 / 22.83Suport & Rezistență

Recent bullish events outweigh bearish events.

All events are bullish.

There is one bearish event.

Sentiment

By Acuity

85 / 365 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

EBITDA

Profit operațional

Despre Prothena Corp PLC

Prothena Corporation PLC is a late-stage clinical company. The Company is engaged in the protein dysregulation and a pipeline of therapeutics for devastating neurodegenerative and rare peripheral amyloid diseases. It is advancing a pipeline of therapeutic candidates around neurological dysfunction and the biology of misfolded proteins. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Birtamimab for the treatment of amyloid light-chain (AL) amyloidosis; prasinezumab for the treatment of Parkinson’s disease and other related synucleinopathies; and PRX004, for the treatment of Transthyretin amyloidosis (ATTR). The Company's pipeline also includes late-preclinical-stage programs targeting proteins implicated in neurological diseases including tau and amyloid beta (Aß) for the treatment of Alzheimer’s disease and other neurodegenerative disorders, and TDP-43 for the treatment of amyotrophic lateral sclerosis.